Cite

HARVARD Citation

    Yin, S. et al. (2018). Trilobatin as an HIV‐1 entry inhibitor targeting the HIV‐1 Gp41 envelope. FEBS letters. 592 (13), pp. 2361-2377. [Online]. 
  
Back to record